Log In
BCIQ
Print this Print this
 

FG3622

  Manage Alerts
Collapse Summary General Information
Company F2G Ltd.
DescriptionFirst-generation systemic antifungal agent
Molecular Target
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPhase I
Standard IndicationFungal infection
Indication DetailsTreat fungal infection
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today